BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
MOLECULAR TARGETUniProt: P45984

MAPK9

mitogen-activated protein kinase 9

43 compounds · BiohacksAI corpus v20260307-01

43
compounds
Compounds
43
Gene Symbol
MAPK9
NCBI Gene
5601

Looking for compounds that interact with MAPK9?

View all 43 compounds →
About MAPK9

MAPK9 (mitogen-activated protein kinase 9) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 43 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.

View MAPK9 on UniProt →
Compounds Targeting MAPK9 (39)
1
Foretinib
4.34
confidence
2
Ponatinib
4.26
confidence
3
Palbociclib
4.22
confidence
4
Nilotinib
4.17
confidence
5
Doramapimod
4.06
confidence
6
Quizartinib
3.99
confidence
7
Midostaurin
3.85
confidence
8
Sb 202190
3.64
confidence
9
Canertinib
3.53
confidence
10
Tae 684
3.43
confidence
11
Fedratinib
3.40
confidence
12
Gilteritinib
3.40
confidence
13
Linifanib
3.33
confidence
14
Sp 600125
3.22
confidence
15
At 9283
3.09
confidence
16
Lestaurtinib
3.04
confidence
117
studies
2.89
confidence
18
Momelotinib
2.89
confidence
19
R 406
2.83
confidence
20
K 252a
2.83
confidence
21
Azd 5438
2.71
confidence
22
Kw 2449
2.64
confidence
23
Linsitinib
2.64
confidence
24
Ast 487
2.56
confidence
25
Zotiraciclib
2.56
confidence
26
Su 014813
2.20
confidence
27
Rebastinib
2.20
confidence
28
Encorafenib
2.20
confidence
29
Cyc 116
2.08
confidence
30
Mk 2461
2.08
confidence
31
Fostamatinib
2.08
confidence
32
Cep 32496
1.95
confidence
33
Tanzisertib
1.95
confidence
297
studies
1.10
confidence
247
studies
1.10
confidence
300
studies
1.10
confidence
180
studies
0.69
confidence
300
studies
0.69
confidence
39
Pictilisibdrugage
0
studies
0.69
confidence
Top 39 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed

All data is computationally derived from published research. Not medical advice. Independent validation required.